Cross Reference Logo
Citations to this article as recorded by CrossRef and RSC Journals (84 citations).

Targeting protein–protein interactions in the DNA damage response pathways for cancer chemotherapy
Kerry Silva McPherson and Dmitry M. Korzhnev
RSC Chem. Biol., 2021, 2, 1167
DOI: 10.1039/D1CB00101A

A straightforward and versatile FeCl3 catalyzed Friedel–Crafts C-glycosylation process. Application to the synthesis of new functionalized C-nucleosides
Hamza Tachallait, Mauro Safir Filho, Hamid Marzag, Khalid Bougrin, Luc Demange, Anthony R. Martin and Rachid Benhida
New J. Chem., 2019, 43, 5551
DOI: 10.1039/C8NJ06300A

Imidazoles as Potential Anticancer Agents: An Update on Recent Studies
Pankaj Sharma, Chris LaRosa, Janet Antwi, Rajgopal Govindarajan and Karl A. Werbovetz
Molecules, 2021, 26, 4213
DOI: 10.3390/molecules26144213

The Combination of ATM and Chk1 Inhibitors Induces Synthetic Lethality in Colorectal Cancer Cells
Yuri Tozaki, Hiromasa Aoki, Rina Kato, Kohki Toriuchi, Saki Arame, Yasumichi Inoue, Hidetoshi Hayashi, Eiji Kubota, Hiromi Kataoka and Mineyoshi Aoyama
Cancers, 2023, 15, 735
DOI: 10.3390/cancers15030735

Phosphorylation state of the histone variant H2A.X controls human stem and progenitor cell fate decisions
Luca Orlando, Borko Tanasijevic, Mio Nakanishi, Jennifer C. Reid, Juan L. García-Rodríguez, Kapil Dev Chauhan, Deanna P. Porras, Lili Aslostovar, Justin D. Lu, Zoya Shapovalova, Ryan R. Mitchell, Allison L. Boyd and Mickie Bhatia
Cell Reports, 2021, 34, 108818
DOI: 10.1016/j.celrep.2021.108818

Modular synthesis of new C-aryl-nucleosides and their anti-CML activity
Hamid Marzag, Marwa Zerhouni, Hamza Tachallait, Luc Demange, Guillaume Robert, Khalid Bougrin, Patrick Auberger and Rachid Benhida
Bioorganic & Medicinal Chemistry Letters, 2018, 28, 1931
DOI: 10.1016/j.bmcl.2018.03.063

Caffeine and Purine Derivatives: A Comprehensive Review on the Chemistry, Biosynthetic Pathways, Synthesis‐Related Reactions, Biomedical Prospectives and Clinical Applications
Ameen A. Abu‐Hashem, Othman Hakami, Mohamed El‐Shazly, Heba A. S. El‐Nashar and Mahmoud N. M. Yousif
Chemistry & Biodiversity, 2024, 21
DOI: 10.1002/cbdv.202400050

Improving the therapeutic ratio of radiotherapy against radioresistant cancers: Leveraging on novel artificial intelligence-based approaches for drug combination discovery
Dennis Jun Jie Poon, Li Min Tay, Dean Ho, Melvin Lee Kiang Chua, Edward Kai-Hua Chow and Eugenia Li Ling Yeo
Cancer Letters, 2021, 511, 56
DOI: 10.1016/j.canlet.2021.04.019

Synergistic effect of inhibiting CHK2 and DNA replication on cancer cell growth
Flavie Coquel, Sing-Zong Ho, Keng-Chang Tsai, Chun-Yen Yang, Antoine Aze, Julie Devin, Ting-Hsiang Chang, Marie Kong-Hap, Audrey Bioteau, Jerome Moreaux, Domenico Maiorano, Philippe Pourquier, Wen-Chin Yang, Yea-Lih Lin and Philippe Pasero
eLife, 2025, 13
DOI: 10.7554/eLife.104718.2

Transición epitelio – mesenquima y cáncer.
Francisco Arvelo and Felipe Sojo
Investigación Clínica, 2023, 64, 379
DOI: 10.54817/IC.v64n3a10

Targeting protein kinases in cancer stem cells
Stephanie Ma, Terence Lee, Chin Ngok Chu and Terence Kin Wah Lee
Essays in Biochemistry, 2022, 66, 399
DOI: 10.1042/EBC20220002

Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer
Patrycja Gralewska, Arkadiusz Gajek, Agnieszka Marczak and Aneta Rogalska
J Hematol Oncol, 2020, 13
DOI: 10.1186/s13045-020-00874-6

Computational fragment-based design of Wee1 kinase inhibitors with tricyclic core scaffolds
Maaged Abdullah and Lalitha Guruprasad
Struct Chem, 2019, 30, 213
DOI: 10.1007/s11224-018-1176-3

Enhancer-driven transcription of MCM8 by E2F4 promotes ATR pathway activation and glioma stem cell characteristics
Yu-meng Sun, Yi-meng Zhang, Hai-liang Shi, Song Yang, Yin-long Zhao, Hong-jiang Liu, Chen Li, Hong-lei Liu, Ji-peng Yang, Jian Song, Guo-zhu Sun and Jian-kai Yang
Hereditas, 2023, 160
DOI: 10.1186/s41065-023-00292-x

Recent advancement of analytical approaches for assessing Ataxia telangiectasia mutated kinase inhibitors in Ataxia telangiectasia: An overview
A. Rameshkumar, V. ArunPrasanna, V. Mahalakshmi, M. Ramkumar Raja and K. Gopinath
Process Biochemistry, 2024, 144, 142
DOI: 10.1016/j.procbio.2024.05.024

Studies on the Design, Synthesis, and Insecticidal Activity Evaluation of New Caffeine-Acrylate Derivatives as Potential Ryanodine Receptor Activators
Yukun Chang, Wei Wei, Haoqin Huang, Yuxin Li, Na Yang, Lixia Xiong and Baolei Wang
J. Agric. Food Chem., 2025
DOI: 10.1021/acs.jafc.5c01744

Mechanisms of Ataxia Telangiectasia Mutated (ATM) Control in the DNA Damage Response to Oxidative Stress, Epigenetic Regulation, and Persistent Innate Immune Suppression Following Sepsis
Laura A. Huff, Shan Yan and Mark G. Clemens
Antioxidants, 2021, 10, 1146
DOI: 10.3390/antiox10071146

Role of Small GTPase RhoA in DNA Damage Response
Chibin Cheng, Daniel Seen, Chunwen Zheng, Ruijie Zeng and Enmin Li
Biomolecules, 2021, 11, 212
DOI: 10.3390/biom11020212

ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms
Jianfeng Shu, Xiaofang Wang, Xuejie Yang and Guofang Zhao
Sci Rep, 2023, 13
DOI: 10.1038/s41598-023-28185-z

Chemoproteomic Selectivity Profiling of PIKK and PI3K Kinase Inhibitors
Maria Reinecke, Benjamin Ruprecht, Sandra Poser, Svenja Wiechmann, Mathias Wilhelm, Stephanie Heinzlmeir, Bernhard Kuster and Guillaume Médard
ACS Chem. Biol., 2019, 14, 655
DOI: 10.1021/acschembio.8b01020

Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
Matthias Schmidt, Alexander Rohe, Charlott Platzer, Abdulkarim Najjar, Frank Erdmann and Wolfgang Sippl
Molecules, 2017, 22, 2045
DOI: 10.3390/molecules22122045

Targeting WEE1 Kinase for Breast Cancer Therapeutics: An Update
Zhao Zhang, Ritika Harish, Naveed Elahi, Sawanjit Saini, Aamir Telia, Manjit Kundlas, Allexes Koroleva, Israel N. Umoh, Manpreet Lota, Meha Bilkhu, Aladdin Kawaiah, Manogna R. Allala, Armelle Leukeu, Emmanuel Nebuwa, Nadiya Sharifi, Anthony W. Ashton, Xuanmao Jiao and Richard G. Pestell
IJMS, 2025, 26, 5701
DOI: 10.3390/ijms26125701

Mucosal Melanoma: Pathological Evolution, Pathway Dependency and Targeted Therapy
Yanni Ma, Ronghui Xia, Xuhui Ma, Robert L. Judson-Torres and Hanlin Zeng
Front. Oncol., 2021, 11
DOI: 10.3389/fonc.2021.702287

Tea Polyphenols Attenuate Methamphetamine-Induced Neuronal Damage in PC12 Cells by Alleviating Oxidative Stress and Promoting DNA Repair
Qin Ru, Qi Xiong, Xiang Tian, Lin Chen, Mei Zhou, Yi Li and Chaoying Li
Front. Physiol., 2019, 10
DOI: 10.3389/fphys.2019.01450

The loss of microglia activities facilitates glaucoma progression in association with CYP1B1 gene mutation (p.Gly61Glu)
Amani Alghamdi, Wadha Aldossary, Sarah Albahkali, Batoul Alotaibi, Bahauddeen M. Alrfaei and Zhejun Cai
PLoS ONE, 2020, 15, e0241902
DOI: 10.1371/journal.pone.0241902

Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
Juan Jin, Hehui Fang, Fang Yang, Wenfei Ji, Nan Guan, Zijia Sun, Yaqin Shi, Guohua Zhou and Xiaoxiang Guan
Neoplasia, 2018, 20, 478
DOI: 10.1016/j.neo.2018.03.003

An Emerging Regulatory Role for the Tumor Microenvironment in the DNA Damage Response to Double-Strand Breaks
Tshering D. Lama-Sherpa and Lalita A. Shevde
Molecular Cancer Research, 2020, 18, 185
DOI: 10.1158/1541-7786.MCR-19-0665

Wee1 Kinase: A Potential Target to Overcome Tumor Resistance to Therapy
Francesca Esposito, Raffaella Giuffrida, Gabriele Raciti, Caterina Puglisi and Stefano Forte
IJMS, 2021, 22, 10689
DOI: 10.3390/ijms221910689

Footprints of microRNAs in Cancer Biology
Yaashini Rajasegaran, Adam Azlan, Aliaa Arina Rosli, Mot Yee Yik, Khor Kang Zi, Narazah Mohd Yusoff and Emmanuel Jairaj Moses
Biomedicines, 2021, 9, 1494
DOI: 10.3390/biomedicines9101494

Circadian clocks in health and disease: Dissecting the roles of the biological pacemaker in cancer
Bridget M. Fortin, Alisa L. Mahieu, Rachel C. Fellows, Nicholas R. Pannunzio and Selma Masri
F1000Res, 2023, 12, 116
DOI: 10.12688/f1000research.128716.2

Hypercellular Proinflammatory Microenvironment Inhibits the Etoposide-Induced DNA Damage in Acute Monocytic Leukemia Cells
Margarita I. Kobyakova, Kirill S. Krasnov, Olga V. Krestinina, Yulia L. Baburina, Anatoly S. Senotov, Yana V. Lomovskaya, Elena I. Meshcheriakova, Alexey I. Lomovsky, Alena I. Zvyagina, Kira V. Pyatina, Irina S. Fadeeva and Roman S. Fadeev
Biochemistry Moscow, 2025, 90, 553
DOI: 10.1134/S000629792560019X

Structure activity relationship and optimization of N -(3-(2-aminothiazol-4-yl)aryl)benzenesulfonamides as anti-cancer compounds against sensitive and resistant cells
Cyril Ronco, Antoine Millet, Magali Plaisant, Patricia Abbe, Nedra Hamouda-Tekaya, Stéphane Rocchi and Rachid Benhida
Bioorganic & Medicinal Chemistry Letters, 2017, 27, 2192
DOI: 10.1016/j.bmcl.2017.03.054

Far-infrared irradiation inhibits breast cancer cell proliferation independently of DNA damage through increased nuclear Ca2+/calmodulin binding modulated-activation of checkpoint kinase 2
Du-Hyong Cho, Hyeon-Ju Lee, Jee Young Lee, Jung-Hyun Park and Inho Jo
Journal of Photochemistry and Photobiology B: Biology, 2021, 219, 112188
DOI: 10.1016/j.jphotobiol.2021.112188

Circadian clocks in health and disease: Dissecting the roles of the biological pacemaker in cancer
Bridget M. Fortin, Alisa L. Mahieu, Rachel C. Fellows, Nicholas R. Pannunzio and Selma Masri
F1000Res, 2023, 12, 116
DOI: 10.12688/f1000research.128716.1

DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
Dana Jurkovicova, Christiana M. Neophytou, Ana Čipak Gašparović and Ana Cristina Gonçalves
IJMS, 2022, 23, 14672
DOI: 10.3390/ijms232314672

Proximal tubule ATR regulates DNA repair to prevent maladaptive renal injury responses
Seiji Kishi, Craig R. Brooks, Kensei Taguchi, Takaharu Ichimura, Yutaro Mori, Akinwande Akinfolarin, Navin Gupta, Pierre Galichon, Bertha C. Elias, Tomohisa Suzuki, Qian Wang, Leslie Gewin, Ryuji Morizane and Joseph V. Bonventre
Journal of Clinical Investigation, 2019, 129, 4797
DOI: 10.1172/JCI122313

Synthesis, 3D-structure and stability analyses of NRPa-308, a new promising anti-cancer agent
Etienne Brachet, Aurore Dumond, Wang-Qing Liu, Marie Fabre, Mohamed Selkti, Françoise Raynaud, Olivier Hermine, Rachid Benhida, Philippe Belmont, Christiane Garbay, Yves Lepelletier, Cyril Ronco, Gilles Pagès and Luc Demange
Bioorganic & Medicinal Chemistry Letters, 2019, 29, 126710
DOI: 10.1016/j.bmcl.2019.126710

GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance by Downregulating NBS1 Transcription in BRAFV600E Colorectal Cancer
Ruowen Zhang, Jinlu Ma, Justin T. Avery, Vijaya Sambandam, Theresa H. Nguyen, Bo Xu, Mark J. Suto and Rebecca J. Boohaker
Front. Oncol., 2020, 10
DOI: 10.3389/fonc.2020.00241

Synthesis, Crystal Structures, Genotoxicity, and Antifungal and Antibacterial Studies of Ni(II) and Cd(II) Pyrazole Amide Coordination Complexes
Amal El Mahdaoui, Smaail Radi, Youssef Draoui, Mohamed El Massaoudi, Sabir Ouahhoud, Abdeslam Asehraou, Nour Eddine Bentouhami, Ennouamane Saalaoui, Redouane Benabbes, Koen Robeyns and Yann Garcia
Molecules, 2024, 29, 1186
DOI: 10.3390/molecules29051186

Novel imidazolone derivatives as potential dual inhibitors of checkpoint kinases 1 and 2: Design, synthesis, cytotoxicity evaluation, and mechanistic insights
Yasmin S. Sheta, Marwa T. Sarg, Fatma G. Abdulrahman, Eman S. Nossier and Ebtehal M. Husseiny
Bioorganic Chemistry, 2024, 149, 107471
DOI: 10.1016/j.bioorg.2024.107471

DNA damage response inhibitors: An avenue for TNBC treatment
Juan Jin, Zhonghua Tao, Jun Cao, Ting Li and Xichun Hu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021, 1875, 188521
DOI: 10.1016/j.bbcan.2021.188521

Natural products targeting the ATR-CHK1 signaling pathway in cancer therapy
Salman Ahmed, Waqas Alam, Michael Aschner, Khalaf F. Alsharif, Ashraf Albrakati, Luciano Saso and Haroon Khan
Biomedicine & Pharmacotherapy, 2022, 155, 113797
DOI: 10.1016/j.biopha.2022.113797

The diverse roles of the circadian clock in cancer
Bridget M. Fortin, Alisa L. Mahieu, Rachel C. Fellows, Yi Kang, Amber N. Lewis, Aya S. Ead, Katja A. Lamia, Yin Cao, Nicholas R. Pannunzio and Selma Masri
Nat Cancer, 2025, 6, 753
DOI: 10.1038/s43018-025-00981-8

Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer
Magdalena Staniszewska, Janette Iking, Katharina Lückerath, Boris Hadaschik, Ken Herrmann, Justin Ferdinandus and Wolfgang P. Fendler
Nuclear Medicine and Biology, 2021, 96-97, 101
DOI: 10.1016/j.nucmedbio.2021.03.009

Polymer nanocarriers for targeted local delivery of agents in treating brain tumors
Alexander D Josowitz, Ranjit S Bindra and W Mark Saltzman
Nanotechnology, 2023, 34, 072001
DOI: 10.1088/1361-6528/ac9683

GLI1: A Therapeutic Target for Cancer
Justin T. Avery, Ruowen Zhang and Rebecca J. Boohaker
Front. Oncol., 2021, 11
DOI: 10.3389/fonc.2021.673154

Enhanced pharmacological activities of AKR1C3‐activated prodrug AST‐3424 in cancer cells with defective DNA repair
Fanying Meng, Tianyang Qi, Xing Liu, Yizhi Wang, Jibing Yu, Zhaoqiang Lu, Xiaohong Cai, Anrong Li, Don Jung and Jianxin Duan
Intl Journal of Cancer, 2025, 156, 417
DOI: 10.1002/ijc.35170

Natural products for combating multidrug resistance in cancer
Ting Chen, Zhicheng Xiao, Xiaoyan Liu, Tingfang Wang, Yun Wang, Fei Ye, Juan Su, Xuan Yao, Liyan Xiong and Dong-Hua Yang
Pharmacological Research, 2024, 202, 107099
DOI: 10.1016/j.phrs.2024.107099

Genomic Profiling of Cardiac Angiosarcoma Reveals Novel Targetable KDR Variants, Recurrent MED12 Mutations, and a High Burden of Germline POT1 Alterations
Igor Odintsov, David J. Papke, Suzanne George, Robert F. Padera, Jason L. Hornick and Stephanie E. Siegmund
Clinical Cancer Research, 2025, 31, 1091
DOI: 10.1158/1078-0432.CCR-24-3277

Modeling the photodynamic effect in 2D versus 3D cell culture under normoxic and hypoxic conditions
Malgorzata Kucinska, Adam Plewinski, Wojciech Szczolko, Mariusz Kaczmarek, Tomasz Goslinski and Marek Murias
Free Radical Biology and Medicine, 2021, 162, 309
DOI: 10.1016/j.freeradbiomed.2020.10.304

Chromosomal instability in HCC: a key function for checkpoint kinase 2
Robert Eferl and Michael Trauner
Gut, 2018, 67, 204
DOI: 10.1136/gutjnl-2017-314101

Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors
Sneha Rathi, Ju-Hee Oh, Wenjuan Zhang, Ann C. Mladek, Darwin A. Garcia, Zhiyi Xue, Danielle M. Burgenske, Wenqiu Zhang, Jiayan Le, Wei Zhong, Jann N. Sarkaria and William F. Elmquist
The Journal of Pharmacology and Experimental Therapeutics, 2024, 390, 260
DOI: 10.1124/jpet.123.001971

Exploiting DNA repair defects in triple negative breast cancer to improve cell killing
Kevin J. Lee, Elise Mann, Griffin Wright, Cortt G. Piett, Zachary D. Nagel and Natalie R. Gassman
Ther Adv Med Oncol, 2020, 12
DOI: 10.1177/1758835920958354

Haemanthamine alters sodium butyrate-induced histone acetylation, p21 WAF1/Cip1 expression, Chk1 and Chk2 activation and leads to increased growth inhibition and death in A2780 ovarian cancer cells
Martina Seifrtová, Radim Havelek, Lucie Cahlíková, Daniela Hulcová, Naděžda Mazánková and Martina Řezáčová
Phytomedicine, 2017, 35, 1
DOI: 10.1016/j.phymed.2017.08.019

Structure-activity relationships of Wee1 inhibitors: A review
Xingkai Du, Jian Li, Xiaojiao Luo, Rong Li, Feng Li, Yiwen Zhang, Jianyou Shi and Jun He
European Journal of Medicinal Chemistry, 2020, 203, 112524
DOI: 10.1016/j.ejmech.2020.112524

Novel quinazolin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity
Monika Pospisilova, Martin Andrs, Martina Seifrtova, Radim Havelek, Daniel Jun, Pavel Tomsik, Lukas Prchal, Rafael Dolezal, Ales Tichy, Tomas Kucera, Jan Korabecny and Martina Rezacova
Bioorganic Chemistry, 2019, 82, 204
DOI: 10.1016/j.bioorg.2018.10.001

The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy
Meiyi Ge, Jian Luo, Yi Wu, Guobo Shen and Xi Kuang
MedComm – Oncology, 2024, 3
DOI: 10.1002/mog2.70

Biguanides drugs: Past success stories and promising future for drug discovery
Oleksandr Grytsai, Iuliia Myrgorodska, Stéphane Rocchi, Cyril Ronco and Rachid Benhida
European Journal of Medicinal Chemistry, 2021, 224, 113726
DOI: 10.1016/j.ejmech.2021.113726

DNA damage response in cancer: New treatment strategies
Hang-Hao Zhang
NC, 2025, 1
DOI: 10.61958/NCWU7206

O2-(2,4-dinitrophenyl) diazeniumdiolate derivative induces G2/M arrest via PTEN-mediated inhibition of PI3K/Akt pathway in hepatocellular carcinoma cells
Ling Liu, Jinglei Xu, Ziyu Zhai, Mengyao Cao, Zile Huang, Yihao Xing and Jingjing Chen
Journal of Pharmacy and Pharmacology, 2021, 73, 1330
DOI: 10.1093/jpp/rgab092

WEE1 inhibition in cancer therapy: Mechanisms, synergies, preclinical insights, and clinical trials
Krishnapriya Thangaretnam, Md Obaidul Islam, Jialun Lv, Ahmed El-Rifai, Ava Perloff, Houda L. Soutto, Dunfa Peng and Zheng Chen
Critical Reviews in Oncology/Hematology, 2025, 211, 104710
DOI: 10.1016/j.critrevonc.2025.104710

Unveiling the anticancer potential of the ethanolic extract from Pometia pinnata: Molecular dynamics targeting CHK1 and cytotoxicity study on MCF-7 cells
Henny Sri Wahyuni, Marianne, Sony Eka Nugraha, Imam Bagus Sumantri, Clara Claudia Jap and Thomi Baihaki Hijriyan
PHAR, 2024, 71, 1
DOI: 10.3897/pharmacia.71.e138556

Emerging serine-threonine kinase inhibitors for treating ovarian cancer
Asaf Maoz, Marcia A. Ciccone, Shinya Matsuzaki, Robert L. Coleman and Koji Matsuo
Expert Opinion on Emerging Drugs, 2019, 24, 239
DOI: 10.1080/14728214.2019.1696773

Diosmetin Inhibits Cell Proliferation, Induces Cell Apoptosis and Cell Cycle Arrest in Liver Cancer
Aiqing Ma and Rui Zhang
CMAR, 2020, Volume 12, 3537
DOI: 10.2147/CMAR.S240064

Targeting DNA Double-Strand Break Repair Pathways to Improve Radiotherapy Response
Mahmoud Toulany
Genes, 2019, 10, 25
DOI: 10.3390/genes10010025

Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed Drugs
Dia Advani and Pravir Kumar
Mol Neurobiol, 2024, 61, 8600
DOI: 10.1007/s12035-024-04130-7

Maintaining Genome Integrity: Protein Kinases and Phosphatases Orchestrate the Balancing Act of DNA Double-Strand Breaks Repair in Cancer
Sisi Qin, Ichiwa Kitty, Yalan Hao, Fei Zhao and Wootae Kim
IJMS, 2023, 24, 10212
DOI: 10.3390/ijms241210212

DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities
María Ovejero-Sánchez, Rogelio González-Sarmiento and Ana Belén Herrero
Cancers, 2023, 15, 448
DOI: 10.3390/cancers15020448

Cross-talk between metabolic alterations and stemness acquisition for the progression, severity and therapy of human breast cancer
Anjali Kumari and Rajakishore Mishra
Scaffold Press Books, 2022, 47
DOI: 10.52679/978-81-952885-6-4_3

Quercetin radiosensitizes non‐small cell lung cancer cells through the regulation of miR‐16‐5p/WEE1 axis
Qi Wang, Yaokun Chen, Haijun Lu, Haiji Wang, Hui Feng, Jinpeng Xu and Biyuan Zhang
IUBMB Life, 2020, 72, 1012
DOI: 10.1002/iub.2242

Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets
Amalia Sofianidi, Ecaterina E. Dumbrava, Konstantinos N. Syrigos and Azadeh Nasrazadani
Cancers, 2024, 16, 1139
DOI: 10.3390/cancers16061139

DNA damage checkpoint kinases in cancer
Hannah L. Smith, Harriet Southgate, Deborah A. Tweddle and Nicola J. Curtin
Expert Rev. Mol. Med., 2020, 22
DOI: 10.1017/erm.2020.3

GCN2 is a determinant of the response to WEE1 kinase inhibition in small-cell lung cancer
Alexandros P. Drainas, Wen-Hao Hsu, Alec E. Dallas, Carson D. Poltorack, Jun W. Kim, Andy He, Garry L. Coles, Maya Baron, Michael C. Bassik and Julien Sage
Cell Reports, 2024, 44, 114606
DOI: 10.1016/j.celrep.2024.114606

The Influence of Cell Cycle Regulation on Chemotherapy
Ying Sun, Yang Liu, Xiaoli Ma and Hao Hu
IJMS, 2021, 22, 6923
DOI: 10.3390/ijms22136923

Small Molecule Docking of DNA Repair Proteins Associated with Cancer Survival Following PCNA Metagene Adjustment: A Potential Novel Class of Repair Inhibitors
Leif E. Peterson
Molecules, 2019, 24, 645
DOI: 10.3390/molecules24030645

DNA Repair and Therapeutic Strategies in Cancer Stem Cells
Matthew S. Gillespie, Ciara M. Ward and Clare C. Davies
Cancers, 2023, 15, 1897
DOI: 10.3390/cancers15061897

Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1
Amirali B. Bukhari, Gordon K. Chan and Armin M. Gamper
Front. Oncol., 2022, 12
DOI: 10.3389/fonc.2022.828684

Mechanisms on chemotherapy resistance of colorectal cancer stem cells and research progress of reverse transformation: A mini-review
Lei Chen, Funing Yang, Si Chen and Jiandong Tai
Front. Med., 2022, 9
DOI: 10.3389/fmed.2022.995882

Expression level of miR-155, miR-15a and miR-19a in peripheral blood of ductal carcinoma breast cancer patients: Possible bioindicators for cellular inherent radiosensitivity
Fatemeh Rajabi and Hossein Mozdarani
Experimental and Molecular Pathology, 2022, 126, 104758
DOI: 10.1016/j.yexmp.2022.104758

Dissociation of the nuclear WWOX/TRAF2 switch renders UV/cold shock-mediated nuclear bubbling cell death at low temperatures
Szu-Jung Chen, Cheng-Chang Tsai, Sing-Ru Lin, Ming-Hui Lee, Shenq-Shyang Huang, Han-Yan Zeng, Lu-Hai Wang, Ming-Fu Chiang, Hamm-Ming Sheu and Nan-Shan Chang
Cell Commun Signal, 2024, 22
DOI: 10.1186/s12964-024-01866-6

Roles of Claspin in regulation of DNA replication, replication stress responses and oncogenesis in human cells
Hao-Wen Hsiao, Chi-Chun Yang and Hisao Masai
GENOME INSTAB. DIS., 2021, 2, 263
DOI: 10.1007/s42764-021-00049-8

Scoulerine affects microtubule structure, inhibits proliferation, arrests cell cycle and thus culminates in the apoptotic death of cancer cells
Klara Habartova, Radim Havelek, Martina Seifrtova, Karel Kralovec, Lucie Cahlikova, Jakub Chlebek, Eva Cermakova, Nadezda Mazankova, Jana Marikova, Jiri Kunes, Lucie Novakova and Martina Rezacova
Sci Rep, 2018, 8
DOI: 10.1038/s41598-018-22862-0

Molecular-Genetic Features of Pancreatic Neuroendocrine Tumors
O. I. Kit, D. Yu. Gvaldin, V. S. Trifanov, E. N. Kolesnikov and N. N. Timoshkina
Russ J Genet, 2020, 56, 142
DOI: 10.1134/S1022795420020064

Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances
Chen Xue, Qingfei Chu, Qingmiao Shi, Yifan Zeng, Juan Lu and Lanjuan Li
Sig Transduct Target Ther, 2025, 10
DOI: 10.1038/s41392-025-02142-w